Evaluating the effect of tumor size and sidedness on prognosis in stage 2 colon cancer: a retrospective population study

被引:0
|
作者
Demir, H. [1 ]
Caglayan, D. [2 ]
Kaman, O. [3 ]
Inanc, M. [4 ]
Urvay, S. [5 ]
Beypinar, I [6 ]
Demirci, A. [7 ]
Davarci, S. E. [1 ]
Araz, M. [2 ]
Baykara, M. [1 ]
Artac, M. [2 ]
Yildiz, F. [3 ]
机构
[1] Afyonkarahisar Hlth Sci Univ, Dept Internal Med & Med Oncol, Sch Med, Afyon, Turkey
[2] Necmettin Erbakan Univ, Dept Internal Med & Med Oncol, Sch Med, Konya, Turkey
[3] Abdurrahman Yurtaslan Ankara Oncol Training & Res, Dept Internal Med & Med Oncol, Ankara, Turkey
[4] Erciyes Univ, Fac Med, Dept Internal Med & Med Oncol, Kayseri, Turkey
[5] Acibadem Univ, Dept Radiotherapy, Vocat Sch Hlth Serv, Istanbul, Turkey
[6] Eskisehir City Hosp, Dept Internal Med & Med Oncol, Eskisehir, Turkey
[7] Sakarya Univ Training & Res Hosp, Dept Med Oncol, Sakarya, Turkey
关键词
Colon cancer; Tumor size; Tumor sidedness; Prognosis; ADJUVANT CHEMOTHERAPY; COLORECTAL-CANCER; SURVIVAL; SURVEILLANCE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: In this study. we aimed to evaluate the effect of tumor size and tumor sidedness on prognosis in patients with stage 2 colon cancer. PATIENTS AND METHODS: Data of 501 patients diagnosed with stage 2 colon cancer were evaluated retrospectively. It was evaluated whether the patients' age, gender, tumor differentiation, tumor node metastasis (TNM) stage, overall survival rate, and disease-free survival rate had any correlation with horizontal tumor diameter and tumor sidedness. In the ROC analysis performed to determine the cut-off value for the tumor diameter, which we think will predict survival, no significant results were obtained with maximum sensitivity and specificity. Therefore, the median value of the tumor diameter, which is 5 cm, was accepted as the cut-off value. Kaplan-Meier method and Cox regression analysis were used for survival analysis and determination of prognostic factors. RESULTS: When the patients were evaluated in terms of tumor localization, 189 (37.7%) patients had right colon tumors and 312 (62.3%) patients had left colon tumors. There was no statistically significant difference in terms of disease-free survival and overall survival according to tumor localization. When the patients were analyzed by dividing them into two groups according to the horizontal tumor size (<5 cm and >= 5 cm), no statistically significant difference was found between the groups in terms of disease-free survival (DFS) and overall survival (OS) p=0.085, p=0.699, respectively. CONCLUSIONS: Our results suggest that the management of patients with stage 2 colon cancer requires a better understanding of tumor biology rather than features such as tumor size and localization.
引用
收藏
页码:1328 / 1340
页数:13
相关论文
共 50 条
  • [21] Appraisal of Prognostic Interaction between Sidedness and Mucinous Histology in Colon Cancer: A Population-Based Study Using Inverse Probability Propensity Score Weighting
    Wang, Zi-Xian
    Yang, Lu-Ping
    Wu, Hao-Xiang
    Yang, Dong-Dong
    Ding, Pei-Rong
    Xie, Dan
    Chen, Gong
    Li, Yu-Hong
    Wang, Feng
    Xu, Rui-Hua
    JOURNAL OF CANCER, 2019, 10 (02): : 388 - 396
  • [22] The Significance of the preoperative lactate dehydrogenase/albumin Ratio in the Prognosis of Colon Cancer: a retrospective study
    Xie, Zhihui
    Zhou, Hui
    Wang, Lei
    Wu, Yibo
    PEERJ, 2022, 10
  • [23] Development and validation of prediction models for the prognosis of colon cancer with lung metastases: a population-based cohort study
    Ma, Zhenyu
    Yang, Shuping
    Yang, Yalin
    Luo, Jingran
    Zhou, Yixiao
    Yang, Huiyong
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [24] Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort study
    Zok, Jolanta
    Bienkowski, Michal
    Radecka, Barbara
    Korniluk, Jan
    Adamowicz, Krzysztof
    Duchnowska, Renata
    BMC CANCER, 2021, 21 (01)
  • [25] Adjuvant chemotherapy improves survival in high- risk stage II colon cancer: a retrospective cohort study
    Liu, Lin-Lin
    Xiang, Zuo-Lin
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [26] The Prognostic Value of Tumor-Infiltrating lymphocytes in Stage II Colon Cancer. A Nationwide Population-Based Study
    Eriksen, Ann C.
    Sorensen, Flemming B.
    Lindebjerg, Jan
    Hager, Henrik
    Christensen, Rene dePont
    Kjaer-Frifeldt, Sanne
    Hansen, Torben F.
    TRANSLATIONAL ONCOLOGY, 2018, 11 (04): : 979 - 987
  • [27] Carcinoma obstruction of the proximal colon cancer and long-term prognosis-obstruction is a predictor of worse outcome in TNM stage II tumor
    Chin, Chih-Chien
    Wang, Jeng-Yi
    Changchien, Chung-Rong
    Huang, Wen-Shih
    Tang, Reiping
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2010, 25 (07) : 817 - 822
  • [28] Differential effect of tumor budding on the benefit of adjuvant chemotherapy in stage II colorectal cancer: a retrospective observational study
    Ran, Xin
    Chen, Yan
    Liu, Chengxiang
    Xiao, He
    Su, Xiaona
    Chen, Zhuo
    Du, Jia
    He, Juan
    Zhong, Peng
    Li, Mengxia
    Dai, Nan
    Chen, Chuan
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (04)
  • [29] Prognostic Significance of Tumor Deposits in Patients With Stage III Colon Cancer: A Nomogram Study
    Zheng, Peilin
    Chen, Qiaoxing
    Li, Jiake
    Jin, Canguang
    Kang, Lina
    Chen, Donghan
    JOURNAL OF SURGICAL RESEARCH, 2020, 245 : 475 - 482
  • [30] Smaller tumor size is associated with poor survival in stage II colon cancer: An analysis of 7,719 patients in the SEER database
    Huang, Ben
    Feng, Yang
    Zhu, Liang
    Xu, Tianhong
    Huang, Liyong
    Cai, Guoxiang
    INTERNATIONAL JOURNAL OF SURGERY, 2016, 33 : 157 - 163